It’s called the “silent surge” — men in their 30s being diagnosed with colon cancer. 7Investigates why their symptoms are often misdiagnosed. Here’s<a class="excerpt-read-more" href=" More ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

Colorectal cancer — which includes cancer of the colon and of the rectum — is considered early onset when diagnosed in people ...

Japanese golf legend Masashi Ozaki died at 78 after battling stage 4 sigmoid colon cancer. The disease develops in the lower ...

Recursion Pharmaceuticals, Inc. upgraded to Buy on promising REC-4881 data, strong partnerships, and AI-driven drug discovery ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in ...

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12) After 12 ...

Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...

SINGAPORE – She was only 12 when she was diagnosed with familial adenomatous polyposis (FAP), an inherited condition that causes hundreds or thousands of polyps to form in the colon and rectum. And ...

Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with ...